Tenax Therapeutics (TENX) Competitors $5.92 +0.16 (+2.69%) Closing price 07/9/2025 02:43 PM EasternExtended Trading$5.93 +0.01 (+0.24%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TENX vs. HURA, IOBT, WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, and JMACShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include TuHURA Biosciences (HURA), IO Biotech (IOBT), Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry. Tenax Therapeutics vs. Its Competitors TuHURA Biosciences IO Biotech Whitehawk Therapeutics OncoCyte Virios Therapeutics Corbus Pharmaceuticals Adagene Entera Bio Oramed Pharmaceuticals Maxpro Capital Acquisition Tenax Therapeutics (NASDAQ:TENX) and TuHURA Biosciences (NASDAQ:HURA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Does the media refer more to TENX or HURA? In the previous week, TuHURA Biosciences had 3 more articles in the media than Tenax Therapeutics. MarketBeat recorded 3 mentions for TuHURA Biosciences and 0 mentions for Tenax Therapeutics. Tenax Therapeutics' average media sentiment score of 0.00 beat TuHURA Biosciences' score of -0.53 indicating that Tenax Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Tenax Therapeutics Neutral TuHURA Biosciences Negative Do institutionals and insiders believe in TENX or HURA? 1.7% of Tenax Therapeutics shares are held by institutional investors. Comparatively, 0.6% of TuHURA Biosciences shares are held by institutional investors. 3.1% of Tenax Therapeutics shares are held by insiders. Comparatively, 0.2% of TuHURA Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher earnings and valuation, TENX or HURA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenax TherapeuticsN/AN/A-$17.60M-$2.48-2.39TuHURA BiosciencesN/AN/A-$21.68MN/AN/A Which has more volatility & risk, TENX or HURA? Tenax Therapeutics has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, TuHURA Biosciences has a beta of 0.17, suggesting that its share price is 83% less volatile than the S&P 500. Do analysts recommend TENX or HURA? Tenax Therapeutics currently has a consensus target price of $17.50, indicating a potential upside of 195.86%. TuHURA Biosciences has a consensus target price of $12.67, indicating a potential upside of 408.70%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe TuHURA Biosciences is more favorable than Tenax Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Is TENX or HURA more profitable? TuHURA Biosciences' return on equity of 291.69% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenax TherapeuticsN/A -31.51% -30.35% TuHURA Biosciences N/A 291.69%122.09% SummaryTuHURA Biosciences beats Tenax Therapeutics on 6 of the 11 factors compared between the two stocks. Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.90M$2.90B$5.51B$8.95BDividend YieldN/A2.44%5.25%4.04%P/E Ratio-2.3921.0128.0220.16Price / SalesN/A246.40405.99173.08Price / CashN/A41.8337.0657.97Price / Book0.227.868.125.62Net Income-$17.60M-$54.96M$3.16B$248.50M7 Day Performance-0.76%5.27%3.14%4.49%1 Month Performance2.34%3.78%3.48%7.03%1 Year Performance77.62%5.85%34.05%21.07% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics1.2569 of 5 stars$5.92+2.7%$17.50+195.9%+85.4%$23.90MN/A-2.399HURATuHURA Biosciences1.2153 of 5 stars$2.23+0.5%$12.67+468.0%N/A$96.97MN/A0.00N/AIOBTIO Biotech3.2619 of 5 stars$1.39-3.5%$9.33+571.5%+22.0%$94.87MN/A-0.9330News CoverageWHWKWhitehawk TherapeuticsN/A$1.87-3.1%N/AN/A$90.92M$25.98M0.0040OCXOncoCyte2.018 of 5 stars$3.18+16.3%$6.06+90.9%+6.2%$90.80M$3.84M-0.90120VIRIVirios TherapeuticsN/A$4.71-1.3%$5.00+6.2%+1,754.4%$90.71MN/A-17.445Gap UpCRBPCorbus Pharmaceuticals3.8187 of 5 stars$6.90-6.8%$50.88+637.3%-83.6%$90.55MN/A-1.6440ADAGAdagene2.0015 of 5 stars$1.95+1.6%$8.00+310.3%-31.6%$90.45M$100K0.00260ENTXEntera Bio2.2409 of 5 stars$1.90-4.0%$10.00+426.3%+1.7%$89.99M$180K-7.3120Positive NewsGap DownORMPOramed PharmaceuticalsN/A$2.25+4.7%N/A-13.2%$87.83M$1.34M-5.1110JMACMaxpro Capital AcquisitionN/A$6.51+1.5%N/A+3,271.7%$87.42MN/A0.002,021 Related Companies and Tools Related Companies TuHURA Biosciences Alternatives IO Biotech Alternatives Whitehawk Therapeutics Alternatives OncoCyte Alternatives Virios Therapeutics Alternatives Corbus Pharmaceuticals Alternatives Adagene Alternatives Entera Bio Alternatives Oramed Pharmaceuticals Alternatives Maxpro Capital Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TENX) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENX Stock Alerts